BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith M, Durham J. Evolving Indications for Tips. Tech Vasc Interv Radiol 2016;19:36-41. [PMID: 26997087 DOI: 10.1053/j.tvir.2016.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chinese Society of Hepatology, Chinese Medical Association. Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, Linghu E, Zhuang H. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatol Int. 2019;13:1-21. [PMID: 30656520 DOI: 10.1007/s12072-018-09923-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
2 Zhang LH, Tong H, Wei B, Wu H, Tang CW. Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis. Chin Med J (Engl) 2017;130:1999-2000. [PMID: 28776556 DOI: 10.4103/0366-6999.211887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol 2017;10:32-41. [PMID: 28286557 DOI: 10.1177/1756283X16671286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
4 Stepanova M, Nader F, Bureau C, Adebayo D, Elkrief L, Valla D, Peck-radosavljevic M, Mccune A, Vargas V, Simon-talero M, Cordoba J, Angeli P, Rossi S, Macdonald S, Capel J, Jalan R, Younossi ZM. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study. Qual Life Res 2018;27:1513-20. [DOI: 10.1007/s11136-018-1813-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
5 Zheng D, Yu J, Li H, Gan H, Wang J, Jiang T, Ren H, Wu F. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series. Medicine (Baltimore) 2021;100:e26610. [PMID: 34232216 DOI: 10.1097/MD.0000000000026610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]